hal-allergy.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | HAL Allergy |
| Description | Producing modified allergen extracts for therapeutic and diagnostic Language: English German Polski Español Österreichisch Italiano Nederlands Menu Company About Us Our Business Model Our Production HAL Allergy Internation |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 94.199.146.85 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
hal-allergy.com Valuation
|
US$2,108,485
Last updated: 2023-05-07 17:37:16
hal-allergy.com has Semrush global rank of 5,019,862. hal-allergy.com has an estimated worth of US$ 2,108,485, based on its estimated Ads revenue. hal-allergy.com receives approximately 243,287 unique visitors each day. Its web server is located in United Kingdom, with IP address 94.199.146.85. According to SiteAdvisor, hal-allergy.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,108,485 |
| Daily Ads Revenue | US$1,947 |
| Monthly Ads Revenue | US$58,389 |
| Yearly Ads Revenue | US$700,666 |
| Daily Unique Visitors | 16,220 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| hal-allergy.com. | A | 300 | IP: 94.199.146.85 |
| hal-allergy.com. | NS | 300 | NS Record: dns1.novagraaf-dns.com. |
| hal-allergy.com. | NS | 300 | NS Record: dns2.novagraaf-dns.net. |
| hal-allergy.com. | NS | 300 | NS Record: dns3.novagraaf-dns.nl. |
| hal-allergy.com. | NS | 300 | NS Record: dns4.novagraaf-dns.eu. |
| hal-allergy.com. | MX | 300 | MX Record: 10 cust52988-1.in.mailcontrol.com. |
| hal-allergy.com. | MX | 300 | MX Record: 10 cust52988-2.in.mailcontrol.com. |
| hal-allergy.com. | TXT | 300 | TXT Record: docusign=1c2adfa7-2402-44a6-a110-d6cd04b4c0cb |
| hal-allergy.com. | TXT | 300 | TXT Record: v=spf1 ip4:46.20.32.130 ip4:46.30.63.40 ip4:94.199.146.85 -all |
| hal-allergy.com. | TXT | 300 | TXT Record: MS=ms93774762 |
| hal-allergy.com. | TXT | 300 | TXT Record: 2q8wg4b61st09z7q1sdyjbm10jcvp4ky |
| hal-allergy.com. | TXT | 300 | TXT Record: 8lw2llgd120p653p9fgqv5vfc80w44hp |
| hal-allergy.com. | TXT | 300 | TXT Record: 93ndxg1l1tdl1bzwjdrypm9t602lk0fj |
| hal-allergy.com. | TXT | 300 | TXT Record: hv25g3yh60gc219wm90w2zny9xjp978c |
HtmlToTextCheckTime:2023-05-07 17:37:16
| Language: English German Polski Español Österreichisch Italiano Nederlands Menu Company About Us Our Business Model Our Production HAL Allergy International Our Management Therapeutics Subcutaneous Immunotherapy Sublingual Immunotherapy Diagnostic R&D Clinical Trial Product Quality Product Pipeline Scientific Advisory Board Careers Vacancies Working at HAL Allergy Benefits & Rewards Mission & Vision Application Process News Expertise in allergy treatment Developing a future-oriented AIT portfolio Changing allergy treatment. Join the change! Producing modified allergen extracts for therapeutic and diagnostic purpose HAL Allergy is one of the European top players in the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. With a highly competitive product portfolio, including subcutaneous and sublingual products, and a future-oriented pipeline portfolio, HAL Allergy strives to provide the best possible medical |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.14.0 (Ubuntu) Date: Thu, 28 Oct 2021 11:51:13 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive location: http://www.hal-allergy.com HTTP/1.1 301 Moved Permanently Date: Thu, 28 Oct 2021 11:51:13 GMT Server: Apache X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://www.hal-allergy.com/ Cache-Control: max-age=0 Expires: Thu, 28 Oct 2021 11:51:13 GMT Content-Type: text/html; charset=UTF-8 HTTP/2 200 date: Thu, 28 Oct 2021 11:51:14 GMT server: Apache vary: User-Agent,Accept-Encoding last-modified: Thu, 28 Oct 2021 11:47:02 GMT accept-ranges: bytes content-length: 636583 cache-control: max-age=0, no-cache, no-store, must-revalidate expires: Mon, 29 Oct 1923 20:30:00 GMT pragma: no-cache content-type: text/html; charset=UTF-8 |
hal-allergy.com Whois Information
Domain Name: HAL-ALLERGY.COM Registry Domain ID: 46060254_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2020-11-04T23:04:41Z Creation Date: 2000-12-04T13:30:02Z Registry Expiry Date: 2021-12-04T13:30:02Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.NOVAGRAAF-DNS.COM Name Server: DNS2.NOVAGRAAF-DNS.NET Name Server: DNS3.NOVAGRAAF-DNS.NL Name Server: DNS4.NOVAGRAAF-DNS.EU DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T04:25:32Z <<< |